Monthly Round-Up of What to Read on Pharma Law and Policy
Bill of Health
MARCH 24, 2023
2023 Feb 25;S0012-3692(23)00301-X. 2023 Feb 7;329(5):386-392. 2023 Feb 13:e226444. 2023 Feb 3;4(2):e225610. Assessment of FDA-Approved Drugs Not Recommended for Use or Reimbursement in Other Countries, 2017-2020. 2023 Feb 13:e226787. Market dynamics of authorized generics in Medicaid from 2014 to 2020.
Let's personalize your content